INSIGHTS ON CLINICAL TRIAL DESIGN

• Antibody-Drug Conjugates: 'Magic Bullets' Become Reality

  Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.

• Are Transportation Failures Really Logistics Problems?

  Missed clinical visits stem from fragmented financial workflows — not transport. Integrating payments, approvals, and travel cuts delays, boosts participation, and keeps studies on track.

• Virtual Clinical Trials For Ophthalmic Measures

  Remote ophthalmic assessments such as BCVA, OCT, and IOP expand trial access and efficiency, preserving data quality while reducing site burden and boosting patient engagement.

• The Difference Between Clinical Trial Auditing And Monitoring

  While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  5/27/2025

  As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.

• It's A Mad Men World For IRB Review Of Clinical Trial Advertisements

  7/13/2026

  Modern digital tools and AI have transformed clinical trial recruitment, outpacing decades-old regulations. Discover how to apply core ethical principles to protect participant privacy and equity.

• Quantitative ROI With DCTs

  11/13/2025

  Through dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.

• The Real Payoff Of Reusable IRT/RTSM System Design

  2/27/2026

  By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.

• Data Key In Addressing Patient Recruitment Challenges

  6/19/2025

  Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.